fulvestrant,abemaciclib,lasofoxifene
ligand,pfizer,sermonix,eli lilly
['abema', ' fulv', 'lasofoxifene', 'elaine-2', 'bcsm']
elaine-2 study (n 29), all post cdk4/6i, esr1-mutated selected hr+her2- #bcsm lasofoxifene + abema orr 55.6%, mpfs 56 weeks . elaine 3 (nct05696626) will compare las/abema with fulv/abema. watch out for dvt risk (n 3/29). #asco23 #postcdk46 
Breast Medical Oncologist @harvardmed @DanaFarber Driven by passion for #research and the one for taking care of #breastcancer patients #bcsm 🇮🇹🇺🇸